David M. Kendall, M.D., Named Distinguished Medical Fello... ( INDIANAPOLIS May 18 2011 /- Eli Lilly...)

David M. Kendall, M.D., Named Distinguished Medical Fellow at Lilly

Date:5/18/2011

INDIANAPOLIS, May 18, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that David M. Kendall, M.D., currently chief scientific and medical officer of the American Diabetes Association, has been named distinguished medical fellow for Lilly. He will transition from his current role in late-July.

In his new role, Kendall will serve as a senior medical advisor for Lilly Diabetes in advocacy and clinical science communities and as a representative to the professional medical community. In addition, he will help provide scientific direction for Lilly in diabetes discovery and clinical development. Other key responsibilities will include the support of Lilly's medical education efforts and diabetes healthcare evaluation programs.

"David brings a critical external view, including the insights he gained while at the American Diabetes Association," said Enrique Conterno, president of Lilly Diabetes. "We are working hard to gain leadership in diabetes care, and that leadership must start with an understanding of the needs of patients and health care providers."

Kendall will report to Robert Heine, M.D., vice president medical affairs, Lilly Diabetes.

"With his background as a clinician, researcher and diabetes advocate, David is the ideal candidate for this position," said Heine. "His focus, passion and understanding of diabetes care will enable us to create ever better solutions for people living with diabetes."

About David Kendall

Kendall joins Lilly Diabetes from the American Diabetes Association, where he serves as scientific and medical officer and has been responsible for the oversight of the Association's research programs, medical affairs, medical education, international affairs, medical information and community programs since 2009.

Kendall also is an associate professor of medicine at the University of Mi
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. The Board of Directors of Kinex Pharmaceuticals Appoints Dr. David Hangauer as Chief Scientific Officer
2. Dr. David B. Samadi Discusses Why Robotic Surgery is Quickly Becoming the Go-To Standard for Prostate Cancer Treatment
3. Law Offices of John David Hart: DePuy Recalled Hip Device Lawsuit Filed by Houston Woman
4. St. Davids HealthCare Takes Robotic-Assisted Surgery to the Next Level With the Texas Institute for Robotic Surgery at St. Davids North Austin Medical Center
5. International Prostate Cancer Treatment Expert Dr. David B. Samadi Supports Kenyan Minister of Medical Services, Peter Anyang Nyongos Decision to Travel to the U.S. for Prostate Cancer Treatment
6. Watson Promotes David Buchen, R. Todd Joyce to Executive Vice President
7. Adeona Mourns the Passing of David A. Newsome, M.D., Senior Vice President of Research & Development
8. Codexis Names David Anton CTO & SVP, Process Development & Manufacturing
9. Cayenne Medical, Inc. Appoints David B. Springer President & CEO
10. Corium International Adds Dr. Bhaskar Chaudhuri and David Greenwood to Board of Directors
11. Robotic Surgery Expert Dr. David Samadi, MD Determines Live Robotic Prostate Cancer Surgeries During Israel Trip A Success

Post Your Comments:

(Date:5/21/2013)... May 21, 2013 Reportlinker.com announces ... available in its catalogue: ... Scenario for Medical Devices in the US ... Changing Regulatory and Reimbursement ... Market Summary ...

(Date:5/21/2013)... Calif. , May 21, 2013 /PRNewswire/ ... ), a specialty pharmaceutical company focused on ... for the treatment of acute and breakthrough ... in a placebo-controlled Phase 3 study of ... analgesia) System (NanoTab System), the primary efficacy ...

(Date:5/21/2013)... and HENDERSONVILLE, N.C. , May ... procurement program for home medical equipment is forcing ... Carolina to lay off employees or close ... of service and products received by Medicare beneficiaries, says ... defective and dangerous program, the Centers for Medicare ...

[0] Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market [0] Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain [0] North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program

... CareFusion today announced an agreement to acquire PHACTS, ... hospital pharmacies better manage inventory, reduce pharmaceutical costs and ... The acquisition will advance CareFusion,s strategy to ... medication throughout their facilities – from the loading ...

... /PRNewswire-Asia/ -- At this very moment, FIRMOO is being heatedly ... of eyeglasses from FIRMOO are being delivered to various countries ... by so many eyeglasses wearers? In this brand new year ... sales platforms, is giving away thousands of free eyeglasses every ...

Cached Medicine Technology:CareFusion To Acquire Pharmacy Automation Technology Leader 2 CareFusion To Acquire Pharmacy Automation Technology Leader 3 CareFusion To Acquire Pharmacy Automation Technology Leader 4 Free Glasses from FIRMOO - Welcome to Your Glasses Kingdom 2 Free Glasses from FIRMOO - Welcome to Your Glasses Kingdom 3

CareFusion To Acquire Pharmacy Automation Technology Leader Free Glasses from FIRMOO - Welcome to Your Glasses Kingdom

(Date:5/21/2013)... 2013 Adeptia, a leading provider of ... announced it is the featured company in an impact ... The report, “Adeptia Bets on Converged Cloud Integration and ... its strategy, products, pricing, customers and competition. ... framework for integration and process orchestration, especially when price, ...

(Date:5/21/2013)... News) -- Chronic obstructive pulmonary disease (COPD) patients ... suggests. Pain levels are nearly on par ... osteoarthritis and rheumatoid arthritis patients, according to the ... the American Thoracic Society annual meeting in Philadelphia. ... pain medication use among COPD patients, and pain ...

(Date:5/21/2013)... 21 (HealthDay News) -- The risk of sudden infant ... sleep with their infant, a new study finds. ... SIDS even if parents do not drink, use illegal ... which is a major cause of infant death in ... sleep with their babies. In the United States, ...

(Date:5/21/2013)... News) -- The monstrous tornado that devastated Moore, ... children, is a stunning example of violent weather ... But even thunderstorms with lightning and strong winds ... Some anxiety in the face of ... storm phobias that interfere with their everyday lives, ...

(Date:5/21/2013)... charged gold nanoparticles are usually toxic to cells, ... toxicity. Mayo Clinic researchers found out why, and ... ovarian cancer cells. The discovery is detailed in ... of Biological Chemistry ., "This study identifies a ... preventing the cell death or apoptosis which should ...

Breaking Medicine News(10 mins):Health News:Adeptia Featured in Recent 451 Research Impact Report 2 Health News:Pain a Common Problem for People With COPD 2 Health News:Bed-Sharing Raises SIDS Risk Fivefold, Study Finds 2 Health News:Weather Worries Can Threaten a Child's Mental Health 2 Health News:Mayo Clinic: How gold nanoparticles can help fight ovarian cancer 2

[0] Adeptia Featured in Recent 451 Research Impact Report [0] Pain a Common Problem for People With COPD [0] Bed-Sharing Raises SIDS Risk Fivefold, Study Finds [0] Weather Worries Can Threaten a Child's Mental Health [0] Mayo Clinic: How gold nanoparticles can help fight ovarian cancer

... most previous work missed key DNA variant, researchers say ... structural changes in DNA called copy number variants may ... who said their findings support a sharp change of ... the past two decades, researchers have identified dozens of ...

... Corporate Governance,TUCSON, Ariz., Feb. 6 The Providence Service ... the recent announcement that an entity controlled by Avalon ... related persons, including Donald E. Smith, the CEO, controlling ... a consent solicitation against the Company. "We have no ...

... EVVV ) will release its 2008 fourth quarter ... on Tuesday, Febuary 24, 2009, before regular market trading hours.The ... day at 7:30 a.m. Central Time (8:30 a.m. Eastern Time). ... operating results and future outlook, followed by a question and ...

... year-to-date revenues increase by 35% over same period ... figures are in Canadian dollars unless otherwise noted),BELLEVILLE, ... Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical ... quarter of its 2009 fiscal year, ending December ...

... The rate of childhood obesity has risen significantly in ... younger ages. At the same time, the number of ... Now a new study finds that, contrary to conventional ... they,re playing outside. , The study, by an interdisciplinary ...

... view simulated results of breast enlargement in 3D, with accurate linear ... ... 5, 2009 -- Toronto Cosmetic Clinic introduces Axis Three,s Portrait 3D ... predicted results of breast augmentation almost instantaneously. ...

Genome Study Points to New Culprit for Schizophrenia Providence Service Corporation Comments on Consent Solicitation by Avalon Correctional Services, Inc.ev3 Inc. to Report 2008 Fourth Quarter and Full-Year Financial Results and Host Conference Call on February 24, 2009 Bioniche Reports Fiscal 2009 Second Quarter Amid rising childhood obesity, preschoolers found to be inactive Toronto Cosmetic Clinic Offers Axis Three Breast Enlargement Imaging for the First Time in Canada

Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....

For use with catalog #0454....

Immuno-turbidimetric Assay of D-Dimer by STA© Analyzers. Microlatex particles coated with two different mouse monoclonal anti-human D-Dimer antibodies....

Medicine Products:

Drugs of Abuse Array Cocaine Metabolite Assay D-DI TEST CARDS D-DI LATEX STA LIATEST D-DI